Funding
MYELOMA
This study is sponsored by Fondazione Italiana Linfomi and was partly funded by Celgene. Romidepsin was provided for free by Celgene. Biological analyses were supported by “Associazione Italiana per la Ricerca sul Cancro” (AIRC) grant number IG22089 (P.I. Prof Paolo Corradini) and by “Associazione Italiana contro le Leucemie-linfomi e myeloma” (AIL) Milano.